NeuroOne Medical Technologies Corporation
NMTC
$0.7716
-$0.009-1.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 22.32% | -57.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 22.32% | -57.65% | |||
| Cost of Revenue | 193.05% | -73.40% | |||
| Gross Profit | -137.36% | -5.06% | |||
| SG&A Expenses | -16.56% | -5.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.90% | 160.18% | |||
| Operating Income | 29.60% | -256.62% | |||
| Income Before Tax | 33.90% | -227.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 33.90% | -227.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.90% | -227.18% | |||
| EBIT | 29.60% | -256.62% | |||
| EBITDA | 30.39% | -247.18% | |||
| EPS Basic | 57.67% | -226.08% | |||
| Normalized Basic EPS | 56.26% | -247.79% | |||
| EPS Diluted | 57.67% | -226.08% | |||
| Normalized Diluted EPS | 56.26% | -248.20% | |||
| Average Basic Shares Outstanding | 56.23% | 0.89% | |||
| Average Diluted Shares Outstanding | 56.23% | 0.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||